Jun 23 2008
Gerresheimer AG, the leading manufacturer of glass and plastic products for the pharma & life science industry, is selling its consumer healthcare business. As previously announced, the Düsseldorf company is thereby discontinuing operations which are not part of the core business of pharmaceutics and life science.
“The consumer healthcare business did not fit in with our strategy of focussing on the fields of pharmaceutics and life science. In addition, because of the lack of synergies with the core business, our return requirements for the consumer healthcare business were not fulfilled,” says Gerresheimer CEO Dr. Axel Herberg.
The consumer healthcare business, which comprises the production of toothbrushes and other interdental articles and most recently achieved annual sales of €24m, was part of the Wilden Group, which was acquired in January 2007. The purchaser is the Krallmann Group. Through the acquisition, Krallmann intends to expand its own plastic processing division and to continue the business under the traditional “Interbros” trademark. The transaction takes place with effect on 1 June 2008. The contractual parties have agreed to keep further details confidential.
Early this year, Gerresheimer already discontinued the marginal business of aluminium packaging with sales of €3.3m.